Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07419295 |
| Title | A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) (TroFuse-031) |
| Acronym | TroFuse-031 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ISR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822) | RECRUITING | Cincinnati | Ohio | 45220 | United States | Details |
| Thompson Cancer Survival Center ( Site 0803) | RECRUITING | Knoxville | Tennessee | 37916 | United States | Details |
| Shaare Zedek Medical Center ( Site 0366) | RECRUITING | Jerusalem | 9103102 | Israel | Details |